Ischemia reperfusion damage in the gut and its treatment with drugs of the aminosalicylic acid group.
Lutz
J
J
Dept. of Physiology, University of Würzburg, Germany.
Augustin
A J
AJ
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000818:Animals; D001547:Benzaldehydes / Q000627:therapeutic use; D005978:Glutathione / Q000031:analogs & derivatives / Q000378:metabolism; D019803:Glutathione Disulfide; D006835:Hydrazones / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000187:drug effects / Q000293:injuries*; D008297:Male; D019804:Mesalamine; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism; D012460:Sulfasalazine / Q000627:therapeutic use; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
D000636:Aminosalicylic Acids; D001547:Benzaldehydes; D006835:Hydrazones; D017392:Thiobarbituric Acid Reactive Substances; D012460:Sulfasalazine; D019804:Mesalamine; C085292:benzalazine; D009195:Peroxidase; D005978:Glutathione; C032587:olsalazine; D019803:Glutathione Disulfide